Clinical Trial Update: AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating AZD0901 in advanced solid tumours expressing Claudin18.2 is currently recruiting, including gastric cancer, gastroesophageal j…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Gastric Cancer
• Gastroesophageal Junction Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• AZD0901

Snippet

Sponsor: AstraZeneca | Conditions: Gastric Cancer, Gastroesophageal Junction Cancer | Phase 2 | Status: RECRUITING